Richard Croarkin - 17 Jun 2021 Form 4 Insider Report for AERIE PHARMACEUTICALS INC (AERI)

Role
Director
Signature
/s/ John LaRocca, Attorney-in-Fact for Richard Croarkin
Issuer symbol
AERI
Transactions as of
17 Jun 2021
Transactions value $
$0
Form type
4
Filing time
21 Jun 2021, 16:11:21 UTC
Previous filing
11 Jun 2021
Next filing
13 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AERI Common Stock Award $0 +1,750 +22% $0 9,850 17 Jun 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AERI Stock Option (right to buy) Award $0 +7,800 $0 7,800 17 Jun 2021 Common Stock 7,800 $16.21 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the reporting person's continued service on the board of directors of the issuer through the vesting date, these shares of Common Stock are scheduled to vest on June 17, 2022.
F2 Subject to the reporting person's continued service on the board of directors of the issuer through the applicable vesting date, this option is scheduled to vest ratably on each of the first 12 monthly anniversaries of June 17, 2021.